Related Experiment Videos

The link between insulin resistance syndrome and inflammatory markers

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

|December 31, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Combination of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter Inhibitors in Type 1 Diabetes: Why, when and How? An Exploration of the Rationale and Clinical Scenarios for Combining These 2 Adjunctive Agents.

Endocrinology and metabolism clinics of North America·2026

Insulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes (TTT1)-An International Phase 3 Clinical Trial.

Diabetes, obesity & metabolism·2026

Use of glucagon-like peptide-1 receptor agonists in people with history of acute pancreatitis: TriNetX analysis.

Diabetes & metabolism·2025

Diabetes surpasses obesity as a risk factor for low serum testosterone level.

Diabetology & metabolic syndrome·2024

Glucose ingestion does not lower testosterone concentrations in men on testosterone therapy.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2024

Glucagon-like peptide-1 receptor agonists as a possible intervention to delay the onset of type 1 diabetes: A new horizon.

World journal of diabetes·2024

See all related articles